Daiichi, J&J Unit Continue Fight For Levaquin Patent
The lawsuit, filed Tuesday in the U.S. District Court for the District of New Jersey, alleges that India-based Lupin Ltd. and its subsidiary, Lupin Pharmaceuticals, are infringing on the patent held by Daiichi and licensed to Johnson & Johnson and its subsidiary Ortho-McNeil Pharmaceutical Inc.
Daiichi has held...
Already a subscriber? Click here to login